Detalles de la búsqueda
1.
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Lancet Oncol;
23(12): 1571-1582, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36370716
2.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
BMC Med;
17(1): 207, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747948
3.
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.
Gynecol Oncol;
154(1): 83-88, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31029508
4.
Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?
Future Oncol;
11(1): 107-19, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25572786
5.
Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials.
EClinicalMedicine;
70: 102501, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38685923
6.
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial.
J Clin Oncol;
41(32): 4976-4981, 2023 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37748109
7.
Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies.
EClinicalMedicine;
59: 101931, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37256095
8.
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study.
Clin Breast Cancer;
21(5): e489-e496, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33342749
9.
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype.
Clin Cancer Res;
26(22): 5843-5851, 2020 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32843527
10.
Early palliative care and quality of life of advanced cancer patients-a multicenter randomized clinical trial.
Ann Palliat Med;
8(4): 381-389, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30943735
11.
Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers.
Cancer Treat Rev;
43: 1-7, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26827687
12.
FCGR, Cetuximab, and Colorectal Cancer Survival-Letter.
Clin Cancer Res;
22(19): 4958, 2016 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27697992
Resultados
1 -
12
de 12
1
Próxima >
>>